AN2 Therapeutics to Present at 2026 Jefferies Global Healthcare Conference in London
AN2 Therapeutics, Inc. (NASDAQ: ANTX) announced that its Co-Founder, Chairman, President, and CEO, Eric Easom, will present at the Jefferies Global Healthcare Conference in London on Monday, November 16, 2026, at 9:30 am GMT. The company, a clinical stage biopharmaceutical firm, will also have management available for one-on-one meetings. A webcast of the presentation will be accessible on the Investors section of the AN2 Therapeutics website.
Put this headline into context
Use TradingAgents AI to connect the story to the company's filings, fundamentals, market structure, competing bull and bear arguments, and risk review.
Headlines and excerpts belong to the original publisher. Ticker associations are informational and may be incomplete. Market news is not personalized financial advice.